Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohort
Nutrition, Metabolism and Cardiovascular Diseases · 2026-10 · 105039
DOI: 10.1016/j.numecd.2026.105039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-10. Verfasst von Yukai Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030000, China. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Health Commission of Shanxi Province.
Abstract (Originalsprache)
BACKGROUND AND AIM: Chronic kidney disease (CKD) and metabolic dysfunction-associated steatotic liver disease (MASLD) coexist, but their bidirectional associations, clinical burden and shared proteomic features remain unclear. METHODS AND RESULTS: UK Biobank cohorts were analysed for CKD-to-MASLD (n = 462,516) and MASLD-to-CKD (n = 438,126) associations using time-dependent Cox models with 1- and 2-year lags. Baseline plasma proteomics from 50,941 participants informed exploratory cross-sectional comparisons and disease-specific LASSO-Cox prediction. A hospital cohort included 32,898 Chinese adults with coding-defined MASLD first admitted during 2018-2023; operational CKD combined diagnostic codes, eGFR and albuminuria. In fully adjusted primary analyses, CKD was associated with incident MASLD (HR = 1.36, 95% CI = 1.26-1.48), and MASLD with incident CKD (HR = 1.64, 95% CI = 1.45-1.85; both P < 0.001). Associations persisted with a 2-year lag. Operational CKD prevalence exceeded discharge-coded CKD (9.23% versus 2.34%), although acute kidney dysfunction could contribute. Each additional cardiovascular-kidney-metabolic comorbidity was associated with higher operational CKD odds (OR = 1.64, 95% CI = 1.56-1.72; P < 0.001). Exploratory profiling identified 41 shared proteins. The 37-protein CKD and 19-protein MASLD scores improved discrimination beyond clinical factors in internal testing and geographical validation within UK Biobank. In internal testing, C-indices rose from 0.780 to 0.844 for CKD and from 0.775 to 0.817 for MASLD. Scores were associated with their corresponding outcomes in internal testing (HR = 2.37 and 1.98) and geographical validation (HR = 2.78 and 2.34; all P < 0.001). FSTL3 and GDF15 were retained in both models, and the two-protein score added predictive information. CONCLUSIONS: Findings support integrated kidney-liver risk assessment, and proteomic features and scores require validation in independent, ethnically diverse non-UK cohorts and across proteomic platforms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030000, China.
- The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, 030000, China. Electronic address: zhouyun_sx@sxmu.edu.cn.
Förderung
- Health Commission of Shanxi Province
Zitieren
APA
Zhang, Y., Zhang, C., & Zhou, Y. (2026). Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohort. Nutrition, Metabolism and Cardiovascular Diseases, 105039. https://doi.org/10.1016/j.numecd.2026.105039
Vancouver
Zhang Y, Zhang C, Zhou Y. Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohort. Nutrition, Metabolism and Cardiovascular Diseases. 2026:105039. doi:10.1016/j.numecd.2026.105039
BibTeX
@article{Zhang2026,
author = {Zhang, Yukai and Zhang, Chenwei and Zhou, Yun},
title = {Bidirectional associations and shared plasma proteomic signatures of CKD and MASLD: evidence from a population-based prospective cohort and a real-world hospital cohort},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
pages = {105039},
doi = {10.1016/j.numecd.2026.105039}
}
EUVIMED